NCT02030457View on ClinicalTrials.gov

A Study to Investigate the Pharmacokinetics and Safety of Beclomethasone Dipropionate Administered by Breath-Actuated Inhaler and Metered-Dose Inhaler in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

April 30, 2014

Study Completion Date

June 30, 2014

Conditions
Pharmacokinetics
Interventions
DRUG

Beclomethasone dipropionate BAI

Breath Activated Inhaler (BAI)

DRUG

Beclomethasone dipropionate MDI

Metered Dose Inhaler (MDI)

Trial Locations (1)

Unknown

Teva Investigational Site, San Antonio

All Listed Sponsors
lead

Teva Branded Pharmaceutical Products R&D, Inc.

INDUSTRY

NCT02030457 - A Study to Investigate the Pharmacokinetics and Safety of Beclomethasone Dipropionate Administered by Breath-Actuated Inhaler and Metered-Dose Inhaler in Healthy Adults | Biotech Hunter | Biotech Hunter